485 related articles for article (PubMed ID: 27357102)
1. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.
Del Gobbo LC; Imamura F; Aslibekyan S; Marklund M; Virtanen JK; Wennberg M; Yakoob MY; Chiuve SE; Dela Cruz L; Frazier-Wood AC; Fretts AM; Guallar E; Matsumoto C; Prem K; Tanaka T; Wu JH; Zhou X; Helmer C; Ingelsson E; Yuan JM; Barberger-Gateau P; Campos H; Chaves PH; Djoussé L; Giles GG; Gómez-Aracena J; Hodge AM; Hu FB; Jansson JH; Johansson I; Khaw KT; Koh WP; Lemaitre RN; Lind L; Luben RN; Rimm EB; Risérus U; Samieri C; Franks PW; Siscovick DS; Stampfer M; Steffen LM; Steffen BT; Tsai MY; van Dam RM; Voutilainen S; Willett WC; Woodward M; Mozaffarian D;
JAMA Intern Med; 2016 Aug; 176(8):1155-66. PubMed ID: 27357102
[TBL] [Abstract][Full Text] [Related]
2. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
Mozaffarian D; Lemaitre RN; King IB; Song X; Huang H; Sacks FM; Rimm EB; Wang M; Siscovick DS
Ann Intern Med; 2013 Apr; 158(7):515-25. PubMed ID: 23546563
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
4. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.
Lemaitre RN; King IB; Mozaffarian D; Kuller LH; Tracy RP; Siscovick DS
Am J Clin Nutr; 2003 Feb; 77(2):319-25. PubMed ID: 12540389
[TBL] [Abstract][Full Text] [Related]
5. Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio Ischemic Heart Disease Risk Factor study.
Virtanen JK; Mursu J; Voutilainen S; Uusitupa M; Tuomainen TP
Diabetes Care; 2014; 37(1):189-96. PubMed ID: 24026545
[TBL] [Abstract][Full Text] [Related]
6. Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies.
Xiao Y; Chen Y; Pietzner A; Elbelt U; Fan Z; Weylandt KH
Nutrients; 2024 May; 16(11):. PubMed ID: 38892543
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
[TBL] [Abstract][Full Text] [Related]
8. Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study.
Wu JH; Lemaitre RN; King IB; Song X; Psaty BM; Siscovick DS; Mozaffarian D
Circulation; 2014 Oct; 130(15):1245-53. PubMed ID: 25124495
[TBL] [Abstract][Full Text] [Related]
9. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study.
Mozaffarian D; Lemaitre RN; King IB; Song X; Spiegelman D; Sacks FM; Rimm EB; Siscovick DS
Ann Intern Med; 2011 Aug; 155(3):160-70. PubMed ID: 21810709
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
[TBL] [Abstract][Full Text] [Related]
11. n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.
Qian F; Ardisson Korat AV; Imamura F; Marklund M; Tintle N; Virtanen JK; Zhou X; Bassett JK; Lai H; Hirakawa Y; Chien KL; Wood AC; Lankinen M; Murphy RA; Samieri C; Pertiwi K; de Mello VD; Guan W; Forouhi NG; Wareham N; Hu ICFB; Riserus U; Lind L; Harris WS; Shadyab AH; Robinson JG; Steffen LM; Hodge A; Giles GG; Ninomiya T; Uusitupa M; Tuomilehto J; Lindström J; Laakso M; Siscovick DS; Helmer C; Geleijnse JM; Wu JHY; Fretts A; Lemaitre RN; Micha R; Mozaffarian D; Sun Q;
Diabetes Care; 2021 May; 44(5):1133-1142. PubMed ID: 33658295
[TBL] [Abstract][Full Text] [Related]
12. Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis.
de Oliveira Otto MC; Wu JH; Baylin A; Vaidya D; Rich SS; Tsai MY; Jacobs DR; Mozaffarian D
J Am Heart Assoc; 2013 Dec; 2(6):e000506. PubMed ID: 24351702
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
[TBL] [Abstract][Full Text] [Related]
14. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction.
Sun Q; Ma J; Campos H; Rexrode KM; Albert CM; Mozaffarian D; Hu FB
Am J Clin Nutr; 2008 Jul; 88(1):216-23. PubMed ID: 18614744
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis.
Wu JH; Micha R; Imamura F; Pan A; Biggs ML; Ajaz O; Djousse L; Hu FB; Mozaffarian D
Br J Nutr; 2012 Jun; 107 Suppl 2(0 2):S214-27. PubMed ID: 22591895
[TBL] [Abstract][Full Text] [Related]
16. Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort.
Pertiwi K; Küpers LK; de Goede J; Zock PL; Kromhout D; Geleijnse JM
J Am Heart Assoc; 2021 Dec; 10(23):e022617. PubMed ID: 34845924
[TBL] [Abstract][Full Text] [Related]
17. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation.
Qian F; Tintle N; Jensen PN; Lemaitre RN; Imamura F; Feldreich TR; Nomura SO; Guan W; Laguzzi F; Kim E; Virtanen JK; Steur M; Bork CS; Hirakawa Y; O'Donoghue ML; Sala-Vila A; Ardisson Korat AV; Sun Q; Rimm EB; Psaty BM; Heckbert SR; Forouhi NG; Wareham NJ; Marklund M; Risérus U; Lind L; Ärnlöv J; Garg P; Tsai MY; Pankow J; Misialek JR; Gigante B; Leander K; Pester JA; Albert CM; Kavousi M; Ikram A; Voortman T; Schmidt EB; Ninomiya T; Morrow DA; Bayés-Genís A; O'Keefe JH; Ong KL; Wu JHY; Mozaffarian D; Harris WS; Siscovick DS;
J Am Coll Cardiol; 2023 Jul; 82(4):336-349. PubMed ID: 37468189
[TBL] [Abstract][Full Text] [Related]
19. N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis.
de Goede J; Verschuren WM; Boer JM; Verberne LD; Kromhout D; Geleijnse JM
PLoS One; 2013; 8(5):e59408. PubMed ID: 23741290
[TBL] [Abstract][Full Text] [Related]
20. Repeated versus single measurement of plasma omega-3 fatty acids and risk of heart failure.
Djoussé L; Petrone AB; Weir NL; Hanson NQ; Glynn RJ; Tsai MY; Gaziano JM
Eur J Nutr; 2014 Sep; 53(6):1403-8. PubMed ID: 24395612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
